Genomic structures of viral agents in relation to the biosynthesis of selenoproteins
- 1 January 1997
- journal article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 56 (1) , 63-91
- https://doi.org/10.1007/bf02778984
Abstract
The genomes of both bacteria and eukaryotic organisms are known to encode selenoproteins, using the UGA codon for selenocysteine (SeC), and a complex cotranslational mechanism for SeC incorporation into polypeptide chains, involving RNA stem-loop structures. These common features and similar codon usage strongly suggest that this is an ancient evolutionary development. However, the possibility that some viruses might also encode selenoproteins remained unexplored until recently. Based on an analysis of the genomic structure of the human immunodeficiency virus HIV-1, we demonstrated that several regions overlapping known HIV genes have the potential to encode selenoproteins (Taylor et al.[31], J. Med. Chem. 37, 2637–2654 [1994]). This is provocative in the light of over-whelming evidence of a role for oxidative stress in AIDS pathogenesis, and the fact that a number of viral diseases have been linked to selenium (Se) deficiency, either in humans or by in vitro and animal studies. These include HIV-AIDS, hepatitis B linked to liver disease and cancer, Coxsackie virus B3, Keshan disease, and the mouse mammary tumor virus (MMTV), against which Se is a potent chemoprotective agent. There are also established biochemical mechanisms whereby extreme Se deficiency can induce a proclotting or hemorrhagic effect, suggesting that hemorrhagic fever viruses should also be examined for potential virally encoded selenoproteins. In addition to the RNA stem-loop structures required for SeC insertion at UGA codons, genomic structural features that may be required for selenoprotein synthesis can also include ribosomal frameshift sites and RNA pseudoknots if the potential selenoprotein module overlaps with another gene, which may prove to be the rule rather than the exception in viruses. One such pseudoknot that we predicted in HIV-1 has now been verified experimentally; a similar structure can be demonstrated in precisely the same location in the reverse transcriptase coding region of hepatitis B virus. Significant new findings reported here include the existence of highly distinctive glutathione peroxidase (GSH-Px)-related sequences in Coxsackie B viruses, new theoretical data related to a previously proposed potential selenoprotein gene overlapping the HIV protease coding region, and further evidence in support of a novel frameshift site in the HIVnef gene associated with a well-conserved UGA codon in the-1 reading frame.Keywords
This publication has 50 references indexed in Scilit:
- Structure of the Autoregulatory Pseudoknot within the Gene 32 Messenger RNA of Bacteriophages T2 and T6: A Model for a Possible Family of Structurally Related RNA PseudoknotsBiochemistry, 1996
- A Basis for New Approaches to the Chemotherapy of AIDS: Novel Genes in HIV-1 Potentially Encode Selenoproteins Expressed by Ribosomal Frameshifting and Termination SuppressionJournal of Medicinal Chemistry, 1994
- Selenium in the maintenance and therapy of HIV-infected patientsChemico-Biological Interactions, 1994
- Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS)Chemico-Biological Interactions, 1994
- Antioxidant status and lipid peroxidation in patients infected with HIVChemico-Biological Interactions, 1994
- Mutational analysis of the “slippery-sequence” component of a coronavirus ribosomal frameshifting signalJournal of Molecular Biology, 1992
- Ribosomal frameshifting, jumping and readthroughCurrent Opinion in Cell Biology, 1991
- EGF‐like domains in extracellular matrix proteins: Localized signals for growth and differentiation?FEBS Letters, 1989
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Inhibition of the genesis of spontaneous mammary tumors in C3H mice: effects of selenium and of selenium-antagonistic elements and their possible role in human breast cancerBioinorganic Chemistry, 1976